Advertisement
Screener

Denali Therapeutics Inc. (DNLI) Other

Denali Therapeutics Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market.
  • 2025-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market.
  • 2024-02-28: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market.
  • 2023-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market.
FiledFormItemAs filed
2026-02-2610-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market
2025-02-2710-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market
2024-02-2810-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market
2023-02-2710-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The Nasdaq Global Select Market
2022-11-0310-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2022-08-0810-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2022-05-0510-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2022-02-2810-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The NASDAQ Global Select Market
2021-11-0410-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2021-08-0410-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2021-05-0510-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2021-02-2610-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The NASDAQ Global Select Market
2020-11-0510-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2020-08-0710-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2020-05-0710-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2020-02-2710-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · The NASDAQ Global Select Market
2019-11-0610-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2019-11-0610-QEmerging growth companyYes
2019-08-0610-QStock registered under Section 12(b)Common Stock, par value $0.01 per share · DNLI · NASDAQ Global Select Market
2019-08-0610-QEmerging growth companyYes
2019-05-0810-QEmerging growth companyYes
2019-03-1210-KEmerging growth companyYes
2018-11-0810-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43